Literature DB >> 16708542

Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma.

Lei Zhang1, Wei-Ping Zhang, Hua Hu, Meng-Ling Wang, Wen-Wen Sheng, Hong-Tian Yao, Wei Ding, Zhong Chen, Er-Qing Wei.   

Abstract

5-Lipoxygenase (5-LOX) is a key enzyme in the metabolism of arachidonic acid to leukotrienes. The levels of leukotrienes increase after brain injury and when tumors are present. It has been reported that 5-LOX is widely expressed in the brain and that 5-LOX inhibition provides neuroprotection. However, there is still no information available for the expression patterns of 5-LOX in human brain following trauma or with astrocytomas. We investigated its expression patterns by immunohistochemistry. We found that 5-LOX is normally expressed in neurons and glial cells. In neurons, it was expressed in two patterns: in the cytosol and nucleus or only in the cytosol. In traumatic brain injury, 5-LOX expression increased in glial cells and neutrophils. Double-labeling immunohistochemistry showed that part of the 5-LOX-positive glial cells were GFAP positive. No 5-LOX expression was found in brain microvessel endothelia, except in the regenerated endothelia of a patient 8 days following brain trauma. Furthermore, 5-LOX expression increased and showed a granular pattern in high-grade (grade III/IV) astrocytoma. These results indicate that 5-LOX has multiple expression patterns, and can be induced by brain injury, which implies that 5-LOX might have pathophysiological roles in the human brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708542     DOI: 10.1111/j.1440-1789.2006.00658.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  18 in total

Review 1.  Therapies targeting lipid peroxidation in traumatic brain injury.

Authors:  Tamil Selvan Anthonymuthu; Elizabeth Megan Kenny; Hülya Bayır
Journal:  Brain Res       Date:  2016-02-10       Impact factor: 3.252

2.  Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

Authors:  Milos D Ikonomovic; Eric E Abrahamson; Tolga Uz; Hari Manev; Steven T Dekosky
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

3.  Suppression of oxidative stress and 5-lipoxygenase activation by edaravone improves depressive-like behavior after concussion.

Authors:  Youichirou Higashi; Michihiro Hoshijima; Toshio Yawata; Atsuya Nobumoto; Masayuki Tsuda; Takahiro Shimizu; Motoaki Saito; Tetuya Ueba
Journal:  J Neurotrauma       Date:  2014-08-21       Impact factor: 5.269

4.  Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme.

Authors:  Elita F da Silveira; Janaine M Chassot; Fernanda C Teixeira; Juliana H Azambuja; Gabriela Debom; Fátima T Beira; Francisco A B Del Pino; Adriana Lourenço; Ana P Horn; Letícia Cruz; Roselia M Spanevello; Elizandra Braganhol
Journal:  Invest New Drugs       Date:  2013-09-27       Impact factor: 3.850

5.  5-Lipoxygenase in mouse cerebellar Purkinje cells.

Authors:  H Chen; S Dzitoyeva; H Manev
Journal:  Neuroscience       Date:  2010-09-17       Impact factor: 3.590

6.  An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.

Authors:  Bin Wang; Shi-cang Yu; Jian-yong Jiang; Gavin Wallace Porter; Lin-tao Zhao; Zhe Wang; Hong Tan; You-hong Cui; Cheng Qian; Yi-fang Ping; Xiu-wu Bian
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

7.  Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis.

Authors:  Xingfu Wang; Yupeng Chen; Sheng Zhang; Lifeng Zhang; Xueyong Liu; Li Zhang; Xiaoling Li; Dayang Chen
Journal:  J Neurooncol       Date:  2015-09-03       Impact factor: 4.130

8.  Caffeic acid attenuates the decrease of cortical BDNF transcript IV mRNA induced by swim stress in wild-type but not in 5-lipoxygenase-deficient mice.

Authors:  Svetlana Dzitoyeva; Marta Imbesi; Tolga Uz; Nikola Dimitrijevic; Hari Manev; Radmila Manev
Journal:  J Neural Transm (Vienna)       Date:  2008-02-28       Impact factor: 3.575

Review 9.  Oxidized phospholipid signaling in traumatic brain injury.

Authors:  Tamil S Anthonymuthu; Elizabeth M Kenny; Andrew M Lamade; Valerian E Kagan; Hülya Bayır
Journal:  Free Radic Biol Med       Date:  2018-06-30       Impact factor: 7.376

10.  RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome.

Authors:  Eric D Hamlett; Erik Hjorth; Aurélie Ledreux; Anah Gilmore; Marianne Schultzberg; Ann Charlotte Granholm
Journal:  Glia       Date:  2020-01-16       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.